BiotechTube
Home/Pipeline/Portfolio of Complex Generics & 505(b)(2) Products

Portfolio of Complex Generics & 505(b)(2) Products

Various

Approved/CommercialActive

Key Facts

Indication
Various
Phase
Approved/Commercial
Status
Active
Company
Alvogen

About Alvogen

Alvogen is a private, US-based generics and specialty pharma company founded in 2009, headquartered in Parsippany, New Jersey. It operates through distinct business units for generics (Alvogen), brand products (Almatica), injectables (Almaject), and US manufacturing (Norwich). The company's strategy centers on building a targeted portfolio of complex products, leveraging partnerships, and maintaining a lean operational structure to bring affordable medicines to market. A recent major transaction was the 2024 sale of its international business to Lotus, creating a leading international specialized generics platform.

View full company profile

Other Various Drugs

DrugCompanyPhase
New Generic ApprovalsChina SXT PharmaceuticalsApplication Submitted / BE Stage
New Dosage Form DevelopmentUniverse PharmaceuticalsDevelopment
New TCM Formula RegistrationUniverse PharmaceuticalsDevelopment
CBD/THC Oil FormulationAvecho BiotechnologyPreclinical
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved
Companion Diagnostics DevelopmentKiffik BiomedicalPre-clinical
Portfolio of 40+ productsPraxgen PharmaceuticalsDevelopment
Drug Repositioning ServiceBiovistaService
Custom Control DevelopmentAnchor MolecularDevelopment/Commercial
Portfolio from Steriscience PartnershipArmas PharmaceuticalsANDA Development/Filing
Generic Medicinal Products DevelopmentBasic PharmaCommercial